title: 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
authors.affiliation: Neurogen Corporation, Branford Connecticut 06405, USA.
authors.forename: A
authors.initials: A
authors.lastname: Thurkauf
authors.forename: J
authors.initials: J
authors.lastname: Yuan
authors.forename: X
authors.initials: X
authors.lastname: Chen
authors.forename: X S
authors.initials: XS
authors.lastname: He
authors.forename: J W
authors.initials: JW
authors.lastname: Wasley
authors.forename: A
authors.initials: A
authors.lastname: Hutchison
authors.forename: K H
authors.initials: KH
authors.lastname: Woodruff
authors.forename: R
authors.initials: R
authors.lastname: Meade
authors.forename: D C
authors.initials: DC
authors.lastname: Hoffman
authors.forename: H
authors.initials: H
authors.lastname: Donovan
authors.forename: D K
authors.initials: DK
authors.lastname: Jones-Hertzog
mesh_terms: D014150:Antipsychotic Agents / Q000737:chemistry*; D003024:Clozapine / Q000031:analogs & derivatives* / Q000737:chemistry; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D050638:Receptors, Dopamine D4
chemical_list: D014150:Antipsychotic Agents; C493599:DRD4 protein, human; D065127:Dopamine D2 Receptor Antagonists; D050638:Receptors, Dopamine D4; D003024:Clozapine